These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29737618)

  • 1. Long-term follow up of 3 T MRI-detected brain lesions after percutaneous catheter-based left atrial appendage closure.
    Bellmann B; Rillig A; Skurk C; Leistner DM; Haeusler KG; Lin T; Geran R; Koehler L; Guttmann S; Tscholl V; Roser M; Lenz K; Villringer K; Wun Park J; Fiebach JB; Landmesser U
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):327-333. PubMed ID: 29737618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imaging-detected brain lesions after percutaneous catheter-based left atrial appendage closure.
    Rillig A; Bellmann B; Skurk C; Leistner DM; Haeusler KG; Lin T; Geran R; Koehler L; Guttmann S; Steffens D; Kasner M; Jakob P; Tscholl V; Roser M; Lenz K; Villringer K; Park JW; Fiebach JB; Landmesser U
    Heart Rhythm; 2018 Jan; 15(1):3-8. PubMed ID: 29304951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome.
    Bellmann B; Schnupp S; Kühnlein P; Javernik C; Kleinecke C; Rillig A; Landmesser U; Brachmann J; Park JW
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):315-320. PubMed ID: 27925332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
    Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study.
    Chen S; Schmidt B; Bordignon S; Bologna F; Nagase T; Tsianakas N; Perrotta L; Chun KRJ
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):291-297. PubMed ID: 29149516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device.
    Luani B; Genz C; Herold J; Mitrasch A; Mitusch J; Wiemer M; Schmeißer A; Braun-Dullaeus RC; Rauwolf T
    BMC Cardiovasc Disord; 2019 May; 19(1):112. PubMed ID: 31092201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
    Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
    Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage closure in the presence of thrombus: A feasibility report.
    Bordignon S; Bologna F; Chen S; Konstantinou A; Tsianakas N; Tohoku S; Trolese L; Chun KJ; Schmidt B
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2858-2863. PubMed ID: 31638713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracardiac vs transesophageal echocardiography for percutaneous left atrial appendage occlusion: A meta-analysis.
    Velagapudi P; Turagam MK; Kolte D; Khera S; Gupta T; Garg J; Abbott JD; George I; Khalique O; Vahl T; Nazif T; Lakkireddy D; Kodali S; Sommer R
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):461-467. PubMed ID: 30585678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Safety of Left Atrial Appendage Closure Using the LAmbre Device in Patients with Nonvalvular Atrial Fibrillation with or Without Prior Catheter Ablation.
    Feng XF; Zhang PP; Sun J; Wang QS; Li YG
    Int Heart J; 2019 Jan; 60(1):63-70. PubMed ID: 30464131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study.
    Huang H; Liu Y; Xu Y; Wang Z; Li Y; Cao K; Zhang S; Yang Y; Yang X; Huang D; Yu B; Su X; Wu L; Huang C
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2188-2194. PubMed ID: 29122133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion Imaging of X-ray and Transesophageal Echocardiography Improves the Procedure of Left Atrial Appendage Closure.
    Ebelt H; Domagala T; Offhaus A; Wiora M; Schwenzky A; Hoyme M; Anacker J; Röhl P
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):781-787. PubMed ID: 32761486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
    Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
    Bellmann B; Fiebach JB; Guttmann S; Lin T; Haeusler KG; Bathe-Peters R; Koehler L; Steffens D; Kasner M; Tscholl V; Nagel P; Roser M; Landmesser U; Rillig A
    Int J Cardiol; 2017 Sep; 243():239-243. PubMed ID: 28592382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of peri-device leaks after interventional left atrial appendage closure using standardized imaging by cardiac computed tomography angiography.
    Lindner S; Behnes M; Wenke A; Sartorius B; Ansari U; Akin M; Mashayekhi K; Vogler N; Haubenreisser H; Schoenberg SO; Borggrefe M; Akin I
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):725-731. PubMed ID: 30421354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.